Assignee
PROPREV AB
SE·2 granted patents·1 pending application·4 citations·filing 2014–2024
Top patents by PatentIndex Score
3 records- 0186US10137157B2Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from PrevotellaPROPREV AB·Filed 2014·Granted Nov 27, 2018·4 cites·14 claims
- 0279US12370226B2Prevotella copri compositionsPROPREV AB·Filed 2024·Granted Jul 29, 2025·0 cites·4 claims
- 0366US2019151376A1Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotellaPROPREV AB·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROPREV AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →